Skip to main content

Table 3 Administrative and clinical outcomes by fluid cohort

From: Erratum to: Impact of intravenous fluid composition on outcomes in patients with systemic inflammatory response syndrome

Outcome/Complication

Saline (n = 1558) % (n)

Balanced (n = 1558) % (n)

Unadjusted odds ratio (95 % CI)

Adjusted odds ratio (95 % CI)

Administrative Outcomes

Cardiac

8.66 (135)

4.43 (69)

0.488 (0.362–0.659)

0.387 (0.276–0.544)

Hemorrhage

0.71 (11)

0.51 (8)

0.726 (0.291–1.809)

0.681 (0.264–1.757)

Infectious

10.14 (158)

6.03 (94)

0.569 (0.436–0.742)

0.526 (0.396–0.699)

Gastrointestinal

5.46 (85)

5.13 (80)

0.938 (0.685–1.284)

0.881 (0.636–1.220)

Neurologic

1.16 (18)

0.83 (13)

0.72 (0.352–1.474)

0.585 (0.275–1.245)

Acute renal failure

4.36 (68)

3.34 (52)

0.757 (0.524–1.093)

0.676 (0.447–1.023)

Respiratory failure

5.46 (85)

3.47 (54)

0.622 (0.439–0.882)

0.624 (0.429–0.908)

New organ failure

9.11 (142)

7.12 (111)

0.765 (0.59–0.991)

0.707 (0.506–0.986)

Clinical Outcomes

Hospital mortality

3.27 (51)

1.03 (16)

0.307 (0.174–0.54)

0.373 (0.204–0.681)

30–day readmissions

9.5 (148)

7.64 (119)

0.788 (0.612–1.014)

0.801 (0.618–1.036)

60–day readmissions

13.54 (211)

10.91 (170)

0.782 (0.63–0.97)

0.804 (0.645–1.004)

90–day readmissions

16.56 (258)

12.58 (196)

0.725 (0.593–0.886)

0.735 (0.598–0.904)

Cardiac

Dysrhythmia

10.65 (166)

6.87 (107)

0.618 (0.48–0.797)

0.632 (0.485–0.823)

Cardiac stress

6.42 (100)

2.05 (32)

0.306 (0.204–0.458)

0.289 (0.188–0.483)

Heart failure

4.04 (63)

1.48 (23)

0.356 (0.219–0.576)

0.447 (0.268–0.747)

Hemorrhage/Hematologic

Coagulopathya

11.09 (150)

7.71 (106)

0.67 (0.516–0.87)

0.602 (0.450–0.806)

Received blood transfusion

2.92 (46)

2.27 (36)

0.777 (0.5–1.209)

0.629 (0.389–1.018)

Bleeding

20.09 (313)

19.96 (311)

0.992 (0.832–1.182)

1.134 (0.942–1.365)

Infectious

    

Pneumonia

6.03 (94)

2.12 (33)

0.337 (0.225–0.504)

0.349 (0.226–0.539)

Sepsis

10.53 (164)

5.65 (88)

0.509 (0.389–0.666)

0.534 (0.401–0.711)

Urinary tract infection

5.91 (92)

4.69 (73)

0.783 (0.571–1.074)

0.884 (0.632–1.237)

Line infection

0.77 (12)

0

Gastrointestinal

Cholecystitis

4.75 (74)

3.53 (55)

0.734 (0.514–1.048)

0.753 (0.517–1.098)

Renal

Acute Kidney Injury

5.46 (85)

4.43 (69)

0.803 (0.580–1.112)

1.052 (0.760–1.455)

Electrolyte Abnormalities

Low magnesium with replacement

4.36 (68)

2.12 (33)

0.474 (0.311–0.723)

0.565 (0.362–0.880)

High magnesium

4.43 (69)

3.4 (53)

0.760 (0.528–1.095)

0.822 (0.553–1.221)

Low potassium with replacement

14.12 (220)

7.51 (117)

0.494 (0.39–0.625)

0.510 (0.393–0.660)

High potassium

9.44 (147)

6.87 (107)

0.708 (0.546–0.918)

0.848 (0.643–1.118)

Low sodium

39.41 (614)

30.62 (477)

0.678 (0.585–0.787)

0.703 (0.602–0.821)

High sodium

7 (109)

6.03 (94)

0.854 (0.642–1.135)

0.965 (0.710–1.311)

Low calcium with replacement

1.16 (18)

0.77 (12)

0.664 (0.319–1.383)

1.125 (0.534–2.369)

Metabolic Acidosis

Lactic (pH and lactate)

0.71 (11)

0.26 (4)

0.362 (0.115–1.139)

0.397 (0.106–1.487)

Metabolic (pH and bicarbonate)

2.76 (43)

1.22 (19)

0.435 (0.252–0.75)

0.749 (0.399–1.403)

Hyperchloremic (pH and chloride)

3.47 (54)

1.22 (19)

0.344 (0.203–0.583)

0.477 (0.262–0.868)

  1. aExcluded patients receiving warfarin